[Federal Register Volume 62, Number 161 (Wednesday, August 20, 1997)]
[Notices]
[Pages 44280-44281]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-22082]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Office of the Secretary


Findings of Scientific Misconduct

AGENCY: Office of the Secretary, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given that the Office of Research Integrity 
(ORI) has made a final finding of scientific misconduct in the 
following case:

[[Page 44281]]

    Shoushu Jiao, M.D., University of Wisconsin: Based upon reports 
from the University of Wisconsin as well as information obtained by the 
Office of Research Integrity (ORI) during its oversight review, ORI 
found that Dr. Jiao, former Research Associate, Department of 
Pediatrics, University of Wisconsin, engaged in scientific misconduct 
by falsifying and creating laboratory records while conducting 
biomedical research. The data in these records were reported in a 
National Institute of Neurological Disorders and Stroke (NINDS), 
National Institutes of Health (NIH) grant application to support a 
request for Public Health Service (PHS) funding. Based on the factual 
findings in the reports, the following article has been retracted: 
Jiao, S., Gurevich, V., & Wolff, J.A. ``Long-term correction of rat 
model of Parkinson's disease by gene therapy.'' Nature 362:450-453, 
1993.
    Dr. Jiao has entered into a Voluntary Exclusion Agreement with ORI 
in which he has voluntarily agreed:
    (1) To exclude himself from serving in any advisory capacity to 
PHS, including but not limited to service on any PHS advisory 
committee, board, and/or peer review committee, or as a consultant for 
a period of four (4) years, beginning on August 8, 1997.
    (2) To exclude himself from any contracting or subcontracting with 
any agency of the United States Government and from eligibility for, or 
involvement in, nonprocurement transactions (e.g., grants and 
cooperative agreements) of the United States Government as defined in 
45 CFR part 76 (Debarment Regulations) for a period of three (3) years, 
beginning on August 8, 1997; and
    (3) That any institution that submits an application for PHS 
support for a research project on which Dr. Jiao's participation is 
proposed, uses him in any capacity on PHS supported research, or 
submits a report of PHS-funded research in which he is involved must 
concurrently submit a plan for supervision of his duties to the funding 
agency for approval for a period of one (1) year following the three 
(3) year exclusion. The supervisory plan must be designed to ensure the 
scientific integrity of Dr. Jiao's research contribution. The 
institution also must submit a copy of the supervisory plan to ORI.

FOR FURTHER INFORMATION CONTACT: Acting Director, Division of Research 
Investigations, Office of Research Integrity, 5515 Security Lane, Suite 
700, Rockville, MD 20852, (301) 443-5330.
Chris B. Pascal,
Acting Director, Office of Research Integrity.
[FR Doc. 97-22082 Filed 8-19-97; 8:45 am]
BILLING CODE 4160-17-P